CTKB Earnings

Quarterly EPS
$0.01
Q3 2024
$0.07
Q4 2024
$-0.09
Q1 2025
$-0.04
Q2 2025
$-0.04
Q3 2025
$-0.34
Q4 2025
$-0.15
Q1 2026
$-0.09
Q2 2026
Latest Revenue48.1M
Latest Net Income-12158000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.0948.1M-12158000+5.6%-125.0%
Q1 2026-$0.1544.1M-18866000+6.5%-66.7%
Q4 2025-$0.3462.1M-44076000+8.1%-585.7%
Q3 2025-$0.0452.3M-5478000+1.5%-500.0%
Q2 2025-$0.0445.6M-5583000-2.2%+50.0%
Q1 2025-$0.0941.5M-11402000-7.6%
Q4 2024$0.0757.5M9.6M-1.3%+75.0%
Q3 2024$0.0151.5M941.0K+7.3%+120.0%
Q2 2024-$0.0846.6M-10434000
Q1 2024$0.0044.9M-6169000
Q4 2023$0.0458.2M5.5M
Q3 2023-$0.0548.0M-6456000
Cytek Biosciences (CTKB) — Earnings